IS7650A - Meðferð við nýrnabilun með beta-inferón - Google Patents
Meðferð við nýrnabilun með beta-inferónInfo
- Publication number
- IS7650A IS7650A IS7650A IS7650A IS7650A IS 7650 A IS7650 A IS 7650A IS 7650 A IS7650 A IS 7650A IS 7650 A IS7650 A IS 7650A IS 7650 A IS7650 A IS 7650A
- Authority
- IS
- Iceland
- Prior art keywords
- inferon
- beta
- treatment
- renal failure
- renal
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L47/00—Traffic control in data switching networks
- H04L47/50—Queue scheduling
- H04L47/62—Queue scheduling characterised by scheduling criteria
- H04L47/6285—Provisions for avoiding starvation of low priority queues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L47/00—Traffic control in data switching networks
- H04L47/10—Flow control; Congestion control
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
- H04L47/00—Traffic control in data switching networks
- H04L47/10—Flow control; Congestion control
- H04L47/215—Flow control; Congestion control using token-bucket
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W28/00—Network traffic management; Network resource management
- H04W28/02—Traffic management, e.g. flow control or congestion control
- H04W28/0252—Traffic management, e.g. flow control or congestion control per individual bearer or channel
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W28/00—Network traffic management; Network resource management
- H04W28/02—Traffic management, e.g. flow control or congestion control
- H04W28/0278—Traffic management, e.g. flow control or congestion control using buffer status reports
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W72/00—Local resource management
- H04W72/20—Control channels or signalling for resource management
- H04W72/23—Control channels or signalling for resource management in the downlink direction of a wireless link, i.e. towards a terminal
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W8/00—Network data management
- H04W8/02—Processing of mobility data, e.g. registration information at HLR [Home Location Register] or VLR [Visitor Location Register]; Transfer of mobility data, e.g. between HLR, VLR or external networks
- H04W8/04—Registration at HLR or HSS [Home Subscriber Server]
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W72/00—Local resource management
- H04W72/12—Wireless traffic scheduling
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Signal Processing (AREA)
- Computer Networks & Wireless Communication (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Databases & Information Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Mobile Radio Communication Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39639302P | 2002-07-17 | 2002-07-17 | |
| PCT/US2003/022440 WO2004006756A2 (en) | 2002-07-17 | 2003-07-17 | THERAPIES FOR RENAL FAILURE USING INTERFERON-β |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7650A true IS7650A (is) | 2005-01-14 |
Family
ID=30116023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7650A IS7650A (is) | 2002-07-17 | 2005-01-14 | Meðferð við nýrnabilun með beta-inferón |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20070025965A1 (is) |
| EP (1) | EP1553971A4 (is) |
| JP (2) | JP4883665B2 (is) |
| KR (2) | KR20110053390A (is) |
| CN (2) | CN1681527A (is) |
| AU (1) | AU2003256603C1 (is) |
| BR (1) | BR0312947A (is) |
| CA (1) | CA2492649A1 (is) |
| EA (1) | EA009938B1 (is) |
| GE (1) | GEP20084499B (is) |
| IL (2) | IL166256A (is) |
| IS (1) | IS7650A (is) |
| MX (1) | MXPA05000658A (is) |
| NO (1) | NO20050827L (is) |
| NZ (1) | NZ538217A (is) |
| PL (1) | PL374914A1 (is) |
| RS (1) | RS20050035A (is) |
| UA (1) | UA88440C2 (is) |
| WO (1) | WO2004006756A2 (is) |
| ZA (1) | ZA200500342B (is) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1811991B1 (en) | 2004-11-10 | 2018-11-07 | Genzyme Corporation | Treatment of type 2 diabetes using inhibitors of glycosphingolipid synthesis |
| CN101282990B (zh) | 2005-08-26 | 2013-04-03 | 阿雷斯贸易股份有限公司 | 糖基化干扰素-β的制备方法 |
| JP5199112B2 (ja) | 2005-12-09 | 2013-05-15 | アレス トレーディング ソシエテ アノニム | Ｆｓｈ又はｆｓｈ変異体を精製するための方法 |
| US10221228B2 (en) | 2006-02-03 | 2019-03-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US8946155B2 (en) | 2006-02-03 | 2015-02-03 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US7553941B2 (en) * | 2006-02-03 | 2009-06-30 | Modigene Inc | Long-acting polypeptides and methods of producing same |
| US8048849B2 (en) | 2006-02-03 | 2011-11-01 | Modigene, Inc. | Long-acting polypeptides and methods of producing same |
| US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| US10351615B2 (en) | 2006-02-03 | 2019-07-16 | Opko Biologics Ltd. | Methods of treatment with long-acting growth hormone |
| US20140113860A1 (en) | 2006-02-03 | 2014-04-24 | Prolor Biotech Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US20150038413A1 (en) | 2006-02-03 | 2015-02-05 | Opko Biologics Ltd. | Long-acting polypeptides and methods of producing and administering same |
| US9458444B2 (en) | 2006-02-03 | 2016-10-04 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| PL2032134T3 (pl) | 2006-05-09 | 2015-11-30 | Genzyme Corp | Sposoby leczenia stłuszczeniowej choroby wątroby obejmujące hamowanie syntezy glikosfingolipidów |
| KR101532369B1 (ko) * | 2006-12-11 | 2015-06-29 | 삼성전자주식회사 | 휴대용 단말기의 원격제어 장치 및 방법 |
| EP2167485B1 (en) | 2007-05-31 | 2015-09-30 | Genzyme Corporation | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| KR20160085917A (ko) | 2007-10-05 | 2016-07-18 | 젠자임 코포레이션 | 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법 |
| AU2008314687A1 (en) * | 2007-10-22 | 2009-04-30 | Merck Serono S.A. | Method for purifying Fc-fusion proteins |
| EP3595264B1 (en) * | 2007-10-27 | 2021-04-07 | BlackBerry Limited | Content disposition system and method for processing message content in a distributed environment |
| PL2234645T3 (pl) * | 2007-12-20 | 2012-10-31 | Merck Serono Sa | Preparaty interferonu-beta modyfikowanego PEG |
| EP2320886B1 (en) * | 2008-07-28 | 2017-06-28 | Genzyme Corporation | Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
| CN102271678B (zh) | 2008-10-03 | 2017-06-30 | 简詹姆公司 | 2‑酰胺基丙醇型葡糖神经酰胺合成酶抑制剂 |
| US9663778B2 (en) | 2009-07-09 | 2017-05-30 | OPKO Biologies Ltd. | Long-acting coagulation factors and methods of producing same |
| CN103228290A (zh) * | 2011-02-18 | 2013-07-31 | (株)斯坦帝尔 | 包含沉默信息调节因子1表达诱导物质的败血症或者败血性休克的预防或者治疗用组合物 |
| WO2013157002A1 (en) | 2012-04-19 | 2013-10-24 | Prolor Biotech Inc. | Long-acting oxyntomodulin variants and methods of producing same |
| CN112661863A (zh) | 2012-11-20 | 2021-04-16 | 奥普科生物制品有限公司 | 通过连接至促性腺激素羧基端肽来增加多肽的流体动力学体积的方法 |
| US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
| EP3988113A1 (en) | 2015-06-19 | 2022-04-27 | OPKO Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
| FI126979B (en) | 2016-02-29 | 2017-09-15 | Faron Pharmaceuticals Oy | Lyophilized pharmaceutical formulation and use thereof |
| BR112019000610A2 (pt) | 2016-07-11 | 2019-07-02 | Opko Biologics Ltd | fator vii de coagulação de longa ação e métodos de produção do mesmo |
| RU2728696C2 (ru) * | 2018-12-28 | 2020-07-30 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Моноклональное антитело к интерферону бета-1а человека |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2210622A1 (en) * | 1995-11-17 | 1997-05-29 | Toray Industries, Inc. | An agent protecting endothelial cells |
| US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| SK287491B6 (sk) * | 1998-10-16 | 2010-11-08 | Biogen Idec Ma Inc. | Fúzne proteíny interferónu- beta-1a a ich použitie |
| US6514729B1 (en) * | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
| US6531122B1 (en) * | 1999-08-27 | 2003-03-11 | Maxygen Aps | Interferon-β variants and conjugates |
| JP2005506957A (ja) * | 2001-06-11 | 2005-03-10 | トランジション・セラピューティックス・インコーポレーテッド | ウイルス性、増殖性および炎症性の疾患の治療のためにビタミンｂ１２およびインターフェロンを用いた複合治療 |
-
2003
- 2003-07-17 US US10/521,513 patent/US20070025965A1/en not_active Abandoned
- 2003-07-17 EP EP03764795A patent/EP1553971A4/en not_active Withdrawn
- 2003-07-17 KR KR1020117009494A patent/KR20110053390A/ko not_active Application Discontinuation
- 2003-07-17 WO PCT/US2003/022440 patent/WO2004006756A2/en active Application Filing
- 2003-07-17 MX MXPA05000658A patent/MXPA05000658A/es active IP Right Grant
- 2003-07-17 CN CNA038221071A patent/CN1681527A/zh active Pending
- 2003-07-17 GE GEAP8638A patent/GEP20084499B/en unknown
- 2003-07-17 JP JP2004521961A patent/JP4883665B2/ja not_active Expired - Fee Related
- 2003-07-17 AU AU2003256603A patent/AU2003256603C1/en not_active Ceased
- 2003-07-17 RS YUP-2005/0035A patent/RS20050035A/sr unknown
- 2003-07-17 KR KR10-2005-7000869A patent/KR20050021502A/ko not_active Application Discontinuation
- 2003-07-17 NZ NZ538217A patent/NZ538217A/en not_active IP Right Cessation
- 2003-07-17 PL PL03374914A patent/PL374914A1/xx unknown
- 2003-07-17 EA EA200500218A patent/EA009938B1/ru not_active IP Right Cessation
- 2003-07-17 UA UAA200501449A patent/UA88440C2/ru unknown
- 2003-07-17 CA CA002492649A patent/CA2492649A1/en not_active Abandoned
- 2003-07-17 BR BRPI0312947-0A patent/BR0312947A/pt not_active IP Right Cessation
- 2003-07-17 CN CN200910178621A patent/CN101664545A/zh active Pending
-
2005
- 2005-01-12 IL IL166256A patent/IL166256A/en not_active IP Right Cessation
- 2005-01-13 ZA ZA200500342A patent/ZA200500342B/en unknown
- 2005-01-14 IS IS7650A patent/IS7650A/is unknown
- 2005-02-16 NO NO20050827A patent/NO20050827L/no not_active Application Discontinuation
-
2009
- 2009-09-13 IL IL200892A patent/IL200892A/en active IP Right Grant
-
2011
- 2011-04-22 JP JP2011096450A patent/JP2011144204A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003256603B2 (en) | 2009-07-30 |
| RS20050035A (en) | 2007-06-04 |
| IL166256A0 (en) | 2006-01-15 |
| BR0312947A (pt) | 2007-07-10 |
| WO2004006756A3 (en) | 2004-08-19 |
| JP2011144204A (ja) | 2011-07-28 |
| EA009938B1 (ru) | 2008-04-28 |
| IL200892A (en) | 2014-11-30 |
| KR20110053390A (ko) | 2011-05-20 |
| WO2004006756A2 (en) | 2004-01-22 |
| CN101664545A (zh) | 2010-03-10 |
| IL200892A0 (en) | 2010-05-17 |
| NO20050827L (no) | 2005-04-15 |
| CN1681527A (zh) | 2005-10-12 |
| EP1553971A4 (en) | 2006-07-05 |
| AU2003256603A1 (en) | 2004-02-02 |
| GEP20084499B (en) | 2008-10-10 |
| PL374914A1 (en) | 2005-11-14 |
| ZA200500342B (en) | 2006-07-26 |
| EA200500218A1 (ru) | 2006-08-25 |
| NZ538217A (en) | 2007-04-27 |
| IL166256A (en) | 2010-11-30 |
| US20070025965A1 (en) | 2007-02-01 |
| UA88440C2 (ru) | 2009-10-26 |
| MXPA05000658A (es) | 2005-08-19 |
| EP1553971A2 (en) | 2005-07-20 |
| KR20050021502A (ko) | 2005-03-07 |
| AU2003256603C1 (en) | 2010-07-15 |
| JP2005537269A (ja) | 2005-12-08 |
| JP4883665B2 (ja) | 2012-02-22 |
| CA2492649A1 (en) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7650A (is) | Meðferð við nýrnabilun með beta-inferón | |
| DE60312848D1 (de) | Verbindungsanschluss | |
| DE60317391D1 (de) | Verbinder | |
| DE60326590D1 (de) | Tend lamotrigin | |
| DE60301239D1 (de) | Verbinder | |
| DE60208885D1 (de) | Verbinder | |
| DE60315937D1 (de) | Verbinder | |
| SE0402458L (sv) | Igensättningsmotverkande behandlingar | |
| DE60223352D1 (de) | Verbinder | |
| DE60218623D1 (de) | Verbinder | |
| DE10301279B8 (de) | Verbinder | |
| DE60312105D1 (de) | Verbinder | |
| DE60311724D1 (de) | Verbinder | |
| DE10394115D2 (de) | Schabewärmetauscher | |
| EA200401429A1 (ru) | Баня | |
| FR2840006B1 (fr) | Construction demontable | |
| DE60326978D1 (de) | Dialysekatheter | |
| FR2845707B1 (fr) | Construction prefabriquee | |
| FR2854917B1 (fr) | Mirador prefabrique | |
| NO20025841D0 (no) | Reguleringsstruktur | |
| AT5889U3 (de) | Brennholzspleisser | |
| FR2836809B1 (fr) | Baignoire | |
| FR2846209B1 (fr) | Structure de couchage | |
| SE0302154D0 (sv) | Menetelmä ja järjestelmä dokumenttien hakutuloksen relevanssin havainnollistamiseksi tiedonhaun oppimis-ja tutkimusympäristöissä sekä dokumenttien hakulaite | |
| EE00386U1 (et) | Pneumohall-bassein |